4-methylamino-3,3-dimethylpiperidine | 396133-45-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 4-methylamino-3,3-dimethylpiperidine
• 英文别名: N,3,3-trimethylpiperidin-4-amine
• CAS: 396133-45-2；544443-26-7；544443-27-8
• 化学式: C₈H₁₈N₂
• 分子量: 142.244
• InChiKey: FHWXHXRRCMIUIK-UHFFFAOYSA-N

物化性质

• 沸点：
  178.6±8.0 °C(Predicted)
• 密度：
  0.89±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  24.1
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-methylamino-3,3-dimethylpiperidine 、 5-amino-1-cyclopropyl-6,7-difluoro-8-methoxy-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid 生成 5-Amino-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(4-methylamino-3,3-dimethyl-1-piperidinyl)-4-oxo-quinoline-3-carboxylic acid
  参考文献：
  名称：

  Inhibitors of cellular efflux pumps of microbes

  摘要：

  本文描述了一种化合物，它是微生物细胞外流泵的外流泵抑制剂。还描述了制备这种化合物的方法、使用这种细胞外流泵抑制剂化合物的方法以及包括这种化合物的药物组成物。

  公开号：

  US07098219B2
• 作为产物：
  描述：

  1-benzyl-4-methylamino-3,3-dimethylpiperidine 在 氢氧化钯 甲醇 作用下， 以 甲醇 、 氢气 为溶剂， 60.0 ℃ 、13.51 MPa 条件下， 反应 6.0h， 以to afford 4-methylamino-3,3-dimethyl-piperidine的产率得到4-methylamino-3,3-dimethylpiperidine
  参考文献：
  名称：

  Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation,compositions and use as medicaments

  摘要：

  本发明涉及新一代三重靶向手性广谱抗微生物7-取代哌啶酮羧酸衍生物，以及它们的光学异构体、对映异构体或对映体，以及药学上可接受的盐、水合物、前药、多晶形和假多晶形，以及它们的制备、组成和使用。

  公开号：

  US20030216568A1

文献信息

• Azaquinazoline Inhibitors Of Atypical Protein Kinase C
  申请人：Ignyta, Inc.

  公开号：US20150274720A1

  公开（公告）日：2015-10-01

  The present application provides a compound of formula (I) and/or a salt thereof, wherein R 1 , G, and X are as defined herein. A compound of formula (I) and/or its salts have aPKC inhibitory activity, and may be used to treat proliferative disorders. Compositions comprising a compound of Formula (I) and/or a salt thereof are also provided.

  本申请提供了一种具有化学式（I）的化合物和/或其盐，其中R1、G和X如本文所定义。化合物的化学式（I）和/或其盐具有aPKC抑制活性，并可用于治疗增生性疾病。还提供了包含化学式（I）的化合物和/或其盐的组合物。
• Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation,compositions and use as medicaments
  申请人：WOCKHARDT LIMITED

  公开号：US20030216568A1

  公开（公告）日：2003-11-20

  This invention relates to new generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, to their optical isomers, diastereomers or enantiomers, as well as pharmaceutically acceptable salts, hydrates, prodrugs, polymorphs and pseudopolymorphs thereof, to their preparation, to their compositions and to their use.

  本发明涉及新一代三重靶向手性广谱抗菌7-取代哌啶酮羧酸衍生物，以及它们的光学异构体、对映异构体或对映体，以及其药学上可接受的盐、水合物、前药、多晶形和假多晶形，以及它们的制备、组成和用途。
• [EN] ENANTIOMERICALLY PURE ADAMANTANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTION<br/>[FR] DÉRIVÉS ÉNANTIOMÉRIQUEMENT PURS D'ADAMATANE POUR LE TRAITEMENT D'INFECTIONS À FILOVIRUS
  申请人：ARISAN THERAPEUTICS INC

  公开号：WO2019018185A1

  公开（公告）日：2019-01-24

  The compounds of the invention as shown by general structure I, as shown below, are effective in treating filovirus infections. Structure I X is selected from the group consisting of O and H; R1 is selected from (C6 to C10) aryl and (C2 to C9) heteroaryl, and R2 is selected from (C1 to C10) alkyl, (C1 to C10) alkenyl, (C1 to C10) alkynyl, (C3 to C10) cycloalkyi, and (C5 to C10) cycloalkenyl, and NR3aR3b is defined in the specification. These compounds are effective in treating filovirii infections including Ebolavirus and Marburgvirus.

  本发明的化合物如一般结构I所示，如下所示，对于治疗丝状病毒感染具有有效性。 结构I中X的选择来自于O和H的群组; R1的选择来自于（C6到C10）芳基和（C2到C9）杂环芳基，而R2的选择来自于（C1到C10）烷基，（C1到C10）烯基，（C1到C10）炔基，（C3到C10）环烷基和（C5到C10）环烯基，而NR3aR3b在规范中被定义。 这些化合物对于治疗丝状病毒感染包括埃博拉病毒和马尔堡病毒具有有效性。
• Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-Quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
  申请人：WOCKHARDT LIMITED

  公开号：US20030096812A1

  公开（公告）日：2003-05-22

  This invention relates to new generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, to their optical isomers, diastereomers or enantiomers, as well as pharmaceutically acceptable salts, hydrates, prodrugs, polymorphs and pseudopolymorphs thereof, to their preparation, to their compositions and to their use.

  本发明涉及新一代三重靶向手性广谱抗微生物7-取代哌啶酮羧酸衍生物，其光学异构体，对映异构体或对映体，以及其药学上可接受的盐，水合物，前药，多晶形和假多晶形，以及其制备，组成和使用。
• New generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
  申请人：De Souza Noel John

  公开号：US20080214608A1

  公开（公告）日：2008-09-04

  This invention relates to new generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, to their optical isomers, diastereomers or enantiomers, as well as pharmaceutically acceptable salts, hydrates, prodrugs, polymorphs and pseudopolymorphs thereof, to their preparation, to their compositions and to their use.

  本发明涉及新一代三重靶向手性广谱抗微生物7-取代哌啶酮羧酸衍生物，以及它们的光学异构体、对映异构体或对映体，以及药学上可接受的盐、水合物、前药、多晶形和伪多晶形，以及它们的制备、组成和使用。